Analyst Price Target is $16.87
▲ +40.67% Upside Potential
This price target is based on 13 analysts offering 12 month price targets for R1 RCM in the last 3 months. The average price target is $16.87, with a high forecast of $22.00 and a low forecast of $11.00. The average price target represents a 40.67% upside from the last price of $11.99.
Current Consensus is
Moderate Buy
The current consensus among 13 contributing investment analysts is to moderate buy stock in R1 RCM. This Moderate Buy consensus rating has held steady for over two years.
R1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers. The company also offers modular solutions, including functional partnership, an outsourcing solutions for improvements across targeted revenue cycle areas for hospital and physician group customers; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance. The company was incorporated in 2003 and is headquartered in Murray, Utah.
Read More
